JPRN-UMIN000022094已完成未知
Comparison of morning Basal + 1 rapid insulin therapy (Insulin Glulisine + Insulin glargine 300 U/ml vs. Insulin lispro + Insulin glargine BS) using continuous glucose monitoring (CGM):randomised crossover study - Comparison of Insulin Glulisine + Insulin glargine 300 U/ml vs. Insulin lispro + Insulin glargine BS using CGM
General Inuyamachuo Hospital Department of Diabetes0 个研究点目标入组 30 人开始时间: 2016年5月2日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •severe renal dysfunction (serum creatinine level over 2.0 mg/dL) judged to be unsuitable for participation for medical reasons
研究者
相似试验
招募中
3 期
Investigating the effect of Gliclazide-MR on glycaemic control in type 2 diabetic patientsIRCT20230910059395N1Oroumia University of Medical Sciences90
进行中（未招募）
1 期
COMPARISON OF A BASAL PLUS ONE INSULIN REGIMEN (INSULIN GLARGINE/INSULIN GLULISINE) WITH A BIPHASIC INSULIN REGIMEN (INSULIN ASPART/INSULIN ASPART PROTAMINE 30/70) IN TYPE 2 DIABETES PATIENTS FOLLOWING BASAL INSULIN OPTIMISATION - LanScapeEUCTR2008-007026-19-GBAventis Pharma Ltd trading as sanofi-aventis780
招募中
不适用
The comparison of basal insulin therapy with average daily risk range (ADRR).Patients with diabetes melliutusJPRN-UMIN000019886MACHIDA MUNICIPAL HOSPITA100
尚未招募
不适用
Comparison of two different techniques(insulin bolus vs glucose insulin infusion) to control blood glucose levels during surgeryCTRI/2017/12/011037Dr Arun P
已完成
不适用
Insulin efficacy in diabetes managementDiabetes mellitusDiabete.E10,E11,E1IRCT2013040812938N1Ronak Daru Company of pharmacy40